Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldstone

Showing results (261-270 of 311) with videos related to

Pageof 32
Sort By:
Bone Marrow Transplantation|April 15, 2003
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantationA J Peniket, M C Ruiz de Elvira, G Taghipour, et al.
Leukemia|April 18, 2002
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemiaM S Jabber Al-Obaidi, M Martineau, C F Bennett, et al.
Leukemia|February 16, 2000
Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemiaR Clark, S A Byatt, C F Bennett, et al.
British Journal of Haematology|March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningWilliam M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphomaT J Smith, B E Hillner, N Schmitz, et al.
British Journal of Haematology|January 31, 1998
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trialD C Linch, D W Milligan, D A Winfield, et al.
Blood|September 6, 2001
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trialsP D Kottaridis, R E Gale, M E Frew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemiaAnthony V Moorman, Claire Schwab, Hannah M Ensor, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Pageof 32

Showing results (261-270 of 311) with videos related to

Sort By:
Pageof 32
Bone Marrow Transplantation|April 15, 2003
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantationA J Peniket, M C Ruiz de Elvira, G Taghipour, et al.
Leukemia|April 18, 2002
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemiaM S Jabber Al-Obaidi, M Martineau, C F Bennett, et al.
Leukemia|February 16, 2000
Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemiaR Clark, S A Byatt, C F Bennett, et al.
British Journal of Haematology|March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningWilliam M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphomaT J Smith, B E Hillner, N Schmitz, et al.
British Journal of Haematology|January 31, 1998
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trialD C Linch, D W Milligan, D A Winfield, et al.
Blood|September 6, 2001
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trialsP D Kottaridis, R E Gale, M E Frew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemiaAnthony V Moorman, Claire Schwab, Hannah M Ensor, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
Blood|December 8, 2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPAAlan K Burnett, Robert K Hills, Claire Green, et al.
Pageof 32